SIGNIFICANT REDUCTIONS OF PATHOGENIC AUTOANTIBODIES BY SYNERGETIC RITUXIMAB AND BELIMUMAB TREATMENT EFFECTIVELY INHIBITS NEUTROPHIL EXTRACELLULAR TRAPS IN SEVERE, REFRACTORY SLE - THE SYNBIOSE STUDY

Author(s):
Kraaij, T.; Kamerling, S.W.; Bakker, J.A. (0000-0002-2918-7361); Huizinga, T.W.; Rabelink, T.J.; Kooten, C. van (0000-0002-6257-0899); Teng, Y.K.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2017), Vol. 76, p. 181-181
hdl
1887/115058
doi
10.1136/annrheumdis-2017-eular.5706